Hymenoptera venom allergy is an epidemiologically underestimated condition representing
an important cause of morbidity worldwide. Preventing future allergic reactions in patients …

Hymenoptera venom allergy (HVA) is the most frequent cause of anaphylaxis in Europe,
accounting for most of the severe reactions occurring in adults, and being the second cause …

This guidance for the management of patients with hymenoptera venom allergy has been
prepared by the Standards of Care Committee (SOCC) of the British Society for Allergy and …

Based on the knowledge of the living conditions and habitat of social Aculeatae a series of
recommendations have been formulated which can potentially greatly minimize the risk of …

Immunotherapy with Hymenoptera venoms is widely used throughout the world and is
accepted as an effective treatment for most patients with Hymenoptera venom allergy. There …

According to most textbooks, diagnostic tests with Hymenoptera venoms are reliable, and
immunotherapy with these venoms in Hymenoptera-venom-allergic patients leads in near to …

Background: Venom immunotherapy (VIT) is regarded as an established and efficient
treatment of Hymenoptera venom allergy. Different frequencies of side‐effects have been …

Allergic reactions to Hymenoptera stings usually present as large local reactions or systemic
reactions with symptoms of immediate type allergy (anaphylaxis). In Central Europe they are …

Background: Hymenoptera venom immunotherapy in allergic patients is a well-established
treatment modality for the prevention of systemic anaphylactic reactions caused by insect …

Hymenoptera venom allergy is a potentially life‐threatening allergic reaction following a
honeybee, vespid, or ant sting. Systemic‐allergic sting reactions have been reported in up to …